Nano-X Imaging Ltd.
corporate_fare Company Profile
Nano-X Imaging Ltd. (NASDAQ:NNOX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 29 items for NNOX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-28, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for NNOX spans 6-K, 424B5.
Recent high-impact activity:
- Nano-X Calls Nov 18 Meeting to Add 300M Shares and Authorize 1-for-20 to 1-for-50 Reverse Split
- Nano-X CFO Guy Nathansohn Resigns for Medical Reasons; Successor Search Begins
- Nanox Flags Going-Concern Doubt as Cash Falls to $26M; Q3 Revenue $4.3-4.4M
- Nanox Flags Going-Concern Doubt as Cash Falls to $26M
- Nano-X Faces Nasdaq Delisting After 30 Days Below $1.00
Financial Snapshot
Short Interest & Short Volume
7.88 days to coverFINRA reported short interest of 6,098,883 shares in NNOX as of the October 15, 2026 settlement, a 3.2% decrease from the prior period — about 7.9 days to cover at its recent average daily volume. On October 28, 2026, 58.9% of NNOX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Moderate riskFiling-implied dilution signals for NNOX, detected from its recent SEC filings · based on capital-structure filings through 2026-08-07.
$8M Registered Direct Offering Priced · Significant Potential Dilution
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
NNOX files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.